Related Experiment Video
Updated: Mar 17, 2026
07:03
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
2.0K
Managing non-alcoholic fatty liver disease
Jing Hieng Ngu1,2, George Boon Bee Goh1,2, Zhongxian Poh3
1Singapore General Hospital, Singapore.
Singapore Medical Journal
|July 22, 2016
Summary
Non-alcoholic fatty liver disease (NAFLD) is a growing global health issue. Early recognition and management, primarily through lifestyle changes, are key to preventing severe liver complications.
Area of Science:
- Hepatology
- Metabolic Diseases
- Public Health
Background:
- Non-alcoholic fatty liver disease (NAFLD) prevalence is rising globally, linked to obesity and diabetes epidemics.
- NAFLD is becoming the leading cause of liver disease worldwide.
- Progression to cirrhosis, hepatocellular carcinoma, and death are serious NAFLD complications.
Purpose of the Study:
- To highlight the increasing prevalence and significance of NAFLD.
- To emphasize the importance of early recognition and intervention for NAFLD.
- To outline current management strategies and referral guidelines for NAFLD patients.
Main Methods:
- This abstract synthesizes current knowledge on NAFLD prevalence, progression, and management.
- It reviews the role of lifestyle modifications and metabolic risk factor control.
- It discusses primary care physician management versus specialist referral criteria.
Main Results:
- NAFLD is a rapidly growing cause of liver disease globally.
- Early detection and intervention are crucial to prevent severe outcomes.
- Most NAFLD patients can be managed in primary care, with specialist referral for advanced fibrosis.
Conclusions:
- NAFLD requires increased recognition due to its rising prevalence and potential for severe complications.
- Lifestyle modifications and metabolic control are fundamental to NAFLD management.
- Timely referral to specialists is essential for NAFLD patients with advanced liver fibrosis.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
01:29Chronic Pancreatitis II: Collaborative Care
461
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
461
01:22Myocarditis IV: Nursing Management
340
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
340
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
1.0K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
1.0K
01:26Diseases of the Liver and Gallbladder
2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
01:26Nephrotic Syndrome II : Assessment and Medical Management
295
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
295